Cell Therapy Bioprocessing Market Size, Share Forecast to 2028

Cell Therapy Bioprocessing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Technology, Cell Type); Indication (Cardiovascular Disease (CVD), Oncology, Wound Healing, Orthopedic, Others); End user (Hospitals and Clinics, Diagnostic Centers, Regenerative Medicine Centers, Academic and Research Institute)

  • Report Code : TIPRE00021550
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 221
Buy Now

Cell Therapy Bioprocessing Market Size, Share Forecast to 2028

Buy Now

The cell therapy bioprocessing is expected to reach US$ 30,052.61 million in 2028 from US$ 11,192.50 million in 2020. The market is estimated to grow with a CAGR of 13.5% from 2021-2028.

The cell therapy bioprocessing market has been analyzed on the basis of technology, cell type, end user, and region. The market based on region is segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. The report emphasizes on parameters such as market trends, technological advancements, market dynamics, and leading company’s competitive landscape analysis to offers insights and in-depth analysis of the cell therapy bioprocessing market. It also includes the analysis of COVID-19 pandemic across the market in all the key regions.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Cell Therapy Bioprocessing Market: Strategic Insights

cell-therapy-bioprocessing-market
Market Size Value inUS$ 11,192.50 Million in 2020
Market Size Value byUS$ 30,052.61 Million by 2028
Growth rateCAGR of 13.5% from 2021-2028
Forecast Period2021-2028
Base Year2021
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Market Insights

Growing Approvals for Cell Therapies

Cell therapies have shown positive results in treating various chronic diseases including rare genetic disorders by offering regenerative medicines and personalized medicines. Increasing need of treating chronic diseases have pushed the research and development activities resulting in growing cell therapy production and product approvals. Few instances are listed below for the cell therapies approvals that have contributed to the growth of the cell therapy bioprocessing market.

  • In May 2019, the Food and Drug Administration (FDA) approved Zolgensma, manufactured by AveXis, Inc. A subsidiary of Novartis AG. Zolgensa is designed to treat spinal muscular atrophy in children below two years and is given by infusing one-time into the vein.
  • In July 2020, Kite Pharma, Inc., a Subsidiary of Gilead Company, received FDA approval for its Tecartus. Tecartus is (CAR) T cell therapy designed to treat refractory mantle cell lymphoma (MCL) in adults. According to toe Gilead Company, Tecartus is the first approved (CAR) T cell therapy for mantle cell lymphoma, which is expected to be a new frontier in the treatment of mantle cell lymphoma.
  • In February 2021, Juno Therapeutics, Inc., a subsidiary of Bristol-Myers Squibb Company, received approval for its Breyanzi. Breyanzi is a cell-based gene therapy intended to treat certain types of large B-cell lymphoma in adults. The treatment is given after patient have not responded to minimum two other types of systemic treatment. However, Breyanzi in 2019, faced regulatory setback since its first filing; it is currently under the European Medicines Agency’s review and was validated in July 2020.

Thus, growing product developments have resulted in various product approvals that reflects the increase in cell therapies. Therefore, it is expected that the growing approvals for cell therapies are enormously increasing the cell therapy bioprocessing, which, in turn is likely to drive the market’s growth over the coming years

Technology-Based Insights

The cell therapy bioprocessing market, by technology, is segmented into bioreactor, lyophilization, electro spinning, controlflow centrifugation, ultrasonic lysis, genome editing technology, cell immortalization technology, and viral vector technology. The Bioreactor segment held the largest share of the market in 2020, whereas the genome editing technology segment is anticipated to register the highest CAGR of 14.5% in the market during the forecast period.

Cell Type-Based Insights

The cell therapy bioprocessing market, by cell type, is segmented into stem cell, immune cell, human embryonic stem cell, pluripotent stem cell, hematopoietic stem cells. The stem cell segment held the largest share of the market in 2020, whereas the same segment is anticipated to register the highest CAGR of 14.0% in the market during the forecast period.

End User-Based Insights

The cell therapy bioprocessing market, by indication, is segmented cardiovascular disease (CVD), oncology, wound healing, orthopedic, and others. The oncology segment held the largest share of the market in 2020, and the orthopedic segment is anticipated to register the highest CAGR of 14.3% in the market during the forecast period.

Companies operating in the cell therapy bioprocessing market are adopting organic strategies such as product launches and expansions to expand their footprint and product portfolio worldwide as well as to address the growing demands.

Cell Therapy Bioprocessing Market Report Scope

By Technology

  • Bioreactor
  • Lyophilization
  • Electrospinning
  • Controlflow Centrifugation
  • Ultrasonic Lysis
  • Genome Editing Technology
  • Cell Immortalization Technology
  • Viral Vector Technology

By Cell Type

  • Stem Cell
  • Immune Cell
  • Human Embryonic Stem Cell
  • Pluripotent Stem Cell
  • Hematopoetic Stem Cell

By Indication

  • Cardiovascular Disease (CVD)
  • Oncology
  • Wound Healing
  • Orthopedic
  • Others

By End User

  • Hospitals and Clinics
  • Diagnostic Centers
  • Regenerative Medicine Centers
  • Academic and Research Institute

By Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East and Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Fresenius Kabi AG                                     
  • Asahi Kasei Corporation                          
  • Sartorius AG                                               
  • MERCK KGaA                                             
  • THERMO FISHER SCIENTIFIC INC.           
  • Corning Incorporated                                
  • Cytiva                                                           
  • Lonza                                                           
  • Repligen                                                      
  • Catalent Inc
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product Type ; Indication ; End user

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What is the cost of Cell Therapy Bioprocessing?

The costs of the Cell Therapy Bioprocessing are much higher, and they may cost US$ 50,000–100,000, or more, per cell therapy. The cost may also differ from product to product types.

What are the driving factors for the Cell Therapy Bioprocessing market across the globe?

Key factors driving the growth of the market are increasing investments for cell and gene therapy manufacturing, and growing approvals for cell therapies are the major factors driving the market growth. However, challenges such as high cost of product, regulatory challenges, and logistics challenges are likely to hinder the growth of the cell therapy bioprocessing market.

What are Cell Therapy Bioprocessing?

Cell therapy bioprocessing is a subfield of bioprocess engineering that bridges cell therapy and bioprocessing (i.e., biopharmaceutical manufacturing). Cell therapy is one of the fastest-growing areas of the life sciences. It entails delivering entire living cells to a patient to treat disease.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Cell Therapy Bioprocessing Market – By Technology

1.3.2 Cell Therapy Bioprocessing Market – By Cell Type

1.3.3 Cell Therapy Bioprocessing Market – By Indication

1.3.4 Cell Therapy Bioprocessing Market – By End User

1.3.5 Cell Therapy Bioprocessing Market– By Geography

2. Cell Therapy Bioprocessing Market– Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Cell Therapy Bioprocessing Market– Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East and Africa PEST Analysis

4.2.5 South and Central America PEST Analysis

4.3 Expert Opinion

5. Cell Therapy Bioprocessing Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Investments for Cell and Gene Therapy Manufacturing

5.1.2 Growing Approvals for Cell Therapies

5.2 Market Restraints

5.2.1 Challenges Associated with Cell Therapy Bioprocessing

5.3 Market Opportunities

5.3.1 Automated Procedures to Produce Cell Therapies

5.4 Future Trends

5.4.1 Digital Biomanufacturing

5.5 Impact Analysis

6. Cell Therapy Bioprocessing Market– Global Analysis

6.1 Global Cell Therapy Bioprocessing Market Revenue Forecast and Analysis

6.2 Global Cell Therapy Bioprocessing Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

7. Cell Therapy Bioprocessing Market Analysis – By Technology

7.1 Overview

7.2 Cell Therapy Bioprocessing Market Revenue Share, by Technology (2020 and 2028)

7.3 Bioreactor

7.3.1 Overview

7.3.2 Bioreactor: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.4 Lyophilization

7.4.1 Overview

7.4.2 Lyophilization: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.5 Electrospinning

7.5.1 Overview

7.5.2 Electrospinning: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.6 Controlflow Centrifugation

7.6.1 Overview

7.6.2 Controlflow Centrifugation: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.7 Ultrasonic Lysis

7.7.1 Overview

7.7.2 Ultrasonic Lysis: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.8 Genome Editing Technology

7.8.1.1 Overview

7.8.2 Genome Editing Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.9 Cell Immortalization Technology

7.9.1 Overview

7.9.2 Cell Immortalization Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.10 Viral Vector Technology

7.10.1.1 Overview

7.10.2 Viral Vector Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

8. Cell Therapy Bioprocessing Market Analysis – By Cell Type

8.1 Overview

8.2 Cell Therapy Bioprocessing Market Revenue Share, by Cell Type (2020 and 2028)

8.3 Stem Cell

8.3.1 Overview

8.3.2 Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

8.4 Immune Cell

8.4.1 Overview

8.4.2 Immune Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

8.5 Human Embryonic Stem Cell

8.5.1 Overview

8.5.2 Human Embryonic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

8.6 Pluripotent Stem Cell

8.6.1 Overview

8.6.2 Pluripotent Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

8.7 Hematopoietic Stem Cell

8.7.1 Overview

8.7.2 Hematopoietic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

9. Cell Therapy Bioprocessing Market Analysis – By Indication

9.1 Overview

9.2 Cell Therapy Bioprocessing Market Revenue Share, by Indication (2020 and 2028)

9.3 Cardiovascular Disease (CVD)

9.3.1 Overview

9.3.2 Cardiovascular Disease (CVD): Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

9.4 Oncology

9.4.1 Overview

9.4.2 Oncology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

9.5 Wound Healing

9.5.1 Overview

9.5.2 Wound Healing: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

9.6 Orthopedic

9.6.1 Overview

9.6.2 Orthopedic: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

9.7 Others

9.7.1 Overview

9.7.2 Others: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

10. Cell Therapy Bioprocessing Market– By End User

10.1 Overview

10.2 Cell Therapy Bioprocessing Market Revenue Share, by End User (2020 and 2028)

10.3 Hospitals and Clinics

10.3.1 Overview

10.3.2 Hospitals and Clinics: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

10.4 Diagnostic Centres

10.4.1 Overview

10.4.2 Diagnostic Centres: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

10.5 Regenerative Medicine Centres

10.5.1 Overview

10.5.2 Regenerative Medicine Centers: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

10.6 Academic and Research Institute

10.6.1 Overview

10.6.2 Academic and Research Institute: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

11. Cell Therapy Bioprocessing Market – Geographical Analysis

11.1 North America: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028

11.1.1 Overview

11.1.2 North America: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.3 North America: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.1.4 North America: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.1.5 North America: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.1.6 North America: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.1.7 North America: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

11.1.8 US: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.1 US: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.2 US: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.1.8.3 US: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.1.8.4 US: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.1.8.5 US: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.1.9 Canada: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.9.1 Canada: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.9.2 Canada: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.1.9.3 Canada: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.1.9.4 Canada: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.1.9.5 Canada: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.1.10 Mexico: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.10.1 Mexico: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.10.2 Mexico: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.1.10.3 Mexico: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.1.10.4 Mexico: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.1.10.5 Mexico: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.2 Europe: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028

11.2.1 Overview

11.2.2 Europe: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.3 Europe: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.2.4 Europe: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.2.5 Europe: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.2.6 Europe: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.2.7 Europe: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

11.2.8 Germany: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.8.1 Germany: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.8.2 Germany: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.2.8.3 Germany: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.2.8.4 Germany: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.2.8.5 Germany: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.2.9 UK: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.9.1 UK: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.9.2 UK: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.2.9.3 UK: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.2.9.4 UK: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.2.9.5 UK: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.2.10 France: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.10.1 France: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.10.2 France: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.2.10.3 France: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.2.10.4 France: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.2.10.5 France: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.2.11 Spain: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.11.1 Spain: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.11.2 Spain: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.2.11.3 Spain: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.2.11.4 Spain: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.2.11.5 Spain: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.2.12 Italy: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.12.1 Italy: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.12.2 Italy: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.2.12.3 Italy: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.2.12.4 Italy: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.2.12.5 Italy: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.2.13 Rest of Europe: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.13.1 Rest of Europe: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.13.2 Rest of Europe: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.2.13.3 Rest of Europe: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.2.13.4 Rest of Europe: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.2.13.5 Rest of Europe: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.3 Asia Pacific: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028

11.3.1 Overview

11.3.2 Asia Pacific: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.3 Asia Pacific: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.3.4 Asia Pacific: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.3.5 Asia Pacific: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.3.6 Asia Pacific: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.3.7 Asia Pacific: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

11.3.8 China: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.8.1 China: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.8.2 China: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.3.8.3 China: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.3.8.4 China: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.3.8.5 China: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.3.9 Japan: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.9.1 Japan: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.9.2 Japan: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.3.9.3 Japan: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.3.9.4 Japan: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.3.9.5 Japan: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.3.10 India: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.10.1 India: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.10.2 India: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.3.10.3 India: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.3.10.4 India: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.3.10.5 India: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.3.11 South Korea: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.11.1 South Korea: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.11.2 South Korea: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.3.11.3 South Korea: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.3.11.4 South Korea: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.3.11.5 South Korea: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.3.12 Australia: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.12.1 Australia: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.12.2 Australia: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.3.12.3 Australia: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.3.12.4 Australia: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.3.12.5 Australia: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.3.13 Rest of Asia Pacific: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.13.1 Rest of Asia Pacific: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.13.2 Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.3.13.3 Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.3.13.4 Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.3.13.5 Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.4 Middle East & Africa: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028

11.4.1 Overview

11.4.2 Middle East & Africa: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.4.3 Middle East & Africa: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.4.4 Middle East & Africa: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.4.5 Middle East & Africa: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.4.6 Middle East & Africa: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.4.7 Middle East & Africa: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

11.4.8 UAE: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.4.8.1 UAE: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.4.8.2 UAE: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.4.8.3 UAE: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.4.8.4 UAE: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.4.8.5 UAE: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.4.9 Saudi Arabia: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.4.9.1 Saudi Arabia: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.4.9.2 Saudi Arabia: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.4.9.3 Saudi Arabia: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.4.9.4 Saudi Arabia: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.4.9.5 Saudi Arabia: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.4.10 South Africa: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.4.10.1 South Africa: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.4.10.2 South Africa: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.4.10.3 South Africa: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.4.10.4 South Africa: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.4.10.5 South Africa: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.4.11 Rest of MEA: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.4.11.1 Rest of MEA: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.4.11.2 Rest of MEA: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.4.11.3 Rest of MEA: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.4.11.4 Rest of MEA: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.4.11.5 Rest of MEA: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.5 South and Central America: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028

11.5.1 Overview

11.5.2 South and Central America: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.5.3 South and Central America: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.5.4 South and Central America: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.5.5 South and Central America: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.5.6 South and Central America: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.5.7 South and Central America: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

11.5.8 Brazil: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.5.8.1 Brazil: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.5.8.2 Brazil: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.5.8.3 Brazil: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.5.8.4 Brazil: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.5.8.5 Brazil: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.5.9 Argentina: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.5.9.1 Argentina: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.5.9.2 Argentina: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.5.9.3 Argentina: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.5.9.4 Argentina: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.5.9.5 Argentina: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.5.10 Rest of SCAM: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.5.10.1 Rest of SCAM: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.5.10.2 Rest of SCAM: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.5.10.3 Rest of SCAM: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.5.10.4 Rest of SCAM: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.5.10.5 Rest of SCAM: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

12. Impact Of COVID-19 Pandemic on Global Cell Therapy Bioprocessing Market

12.1 North America: Impact Assessment of COVID-19 Pandemic

12.2 Europe: Impact Assessment of COVID-19 Pandemic

12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

12.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

12.5 South & Central America: Impact Assessment of COVID-19 Pandemic

13. Cell Therapy Bioprocessing Market–Industry Landscape

13.2 Growth Strategies Done by the Companies in the Market, (%)

13.3 Organic Developments

13.3.1 Overview

13.4 Inorganic Developments

13.4.1 Overview

14. Company Profiles

14.1 Fresenius Kabi AG

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Asahi Kasei Corporation

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Sartorius AG

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 MERCK KGaA

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 THERMO FISHER SCIENTIFIC INC.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Corning Incorporated

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Cytiva

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Lonza

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Repligen

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Catalent Inc

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About the Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. North America: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 2. North America: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 3. North America: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 4. North America: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5. US: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 6. US: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 7. US: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 8. US: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. Canada: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 10. Canada: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 11. Canada: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 12. Canada: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13. Mexico: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 14. Mexico: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 15. Mexico: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 16. Mexico: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17. Europe: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 18. Europe: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 19. Europe: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 20. Europe: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 21. Germany: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 22. Germany: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 23. Germany: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 24. Germany: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 25. UK: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 26. UK: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 27. UK: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 28. UK: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 29. France: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 30. France: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 31. France: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 32. France: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 33. Spain: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 34. Spain: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 35. Spain: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 36. Spain: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 37. Italy: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 38. Italy: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 39. Italy: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 40. Italy: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 41. Rest of Europe: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 42. Rest of Europe: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 43. Rest of Europe: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 44. Rest of Europe: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 45. Asia Pacific: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 46. Asia Pacific: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 47. Asia Pacific: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 48. Asia Pacific: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 49. China: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 50. China: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 51. China: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 52. China: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 53. Japan: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 54. Japan: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 55. Japan: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 56. Japan: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 57. India: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 58. India: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 59. India: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 60. India: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 61. South Korea: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 62. South Korea: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 63. South Korea: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 64. South Korea: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 65. Australia: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 66. Australia: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 67. Australia: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 68. Australia: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 69. Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 70. Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 71. Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 72. Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 73. Middle East & Africa: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 74. Middle East & Africa: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 75. Middle East & Africa: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 76. Middle East & Africa: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 77. UAE: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 78. UAE: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 79. UAE: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 80. UAE: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 81. Saudi Arabia: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 82. Saudi Arabia: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 83. Saudi Arabia: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 84. Saudi Arabia: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 85. South Africa: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 86. South Africa: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 87. South Africa: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 88. South Africa: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 89. Rest of MEA: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 90. Rest of MEA: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 91. Rest of MEA: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 92. Rest of MEA: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 93. South and Central America: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 94. South and Central America: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 95. South and Central America: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 96. South and Central America: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 97. Brazil: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 98. Brazil: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 99. Brazil: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 100. Brazil: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 101. Argentina: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 102. Argentina: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 103. Argentina: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 104. Argentina: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 105. Rest of SCAM: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 106. Rest of SCAM: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 107. Rest of SCAM: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 108. Rest of SCAM: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 109. Organic Developments Done By Companies

Table 110. Inorganic Developments Done By Companies

Table 111. Glossary of Terms, Cell Therapy Bioprocessing Market

LIST OF FIGURES

Figure 1. Cell Therapy Bioprocessing Market Segmentation

Figure 2. Cell Therapy Bioprocessing Segmentation, By Region

Figure 3. Global Cell Therapy Bioprocessing Market Overview

Figure 4. Bioreactor Held Largest Share of Technology Segment in Cell Therapy Bioprocessing Market

Figure 5. Asia Pacific to Show Remarkable Growth During Forecast Period

Figure 6. Cell Therapy Bioprocessing Market, by Geography (US$ Million)

Figure 7. Global Cell Therapy Bioprocessing Market– Leading Country Markets (US$ Million)

Figure 8. Global Cell Therapy Bioprocessing Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia Pacific: PEST Analysis

Figure 12. Middle East and Africa: PEST Analysis

Figure 13. South and Central America: PEST Analysis

Figure 14. Expert Opinion

Figure 15. Cell Therapy Bioprocessing Market Impact Analysis of Drivers and Restraints

Figure 16. Global Cell Therapy Bioprocessing Market– Revenue Forecast and Analysis – 2020- 2028

Figure 17. Global Cell Therapy Bioprocessing Market– By Geography Forecast and Analysis – 2020- 2028

Figure 18. Market Positioning of Key Players in Global Cell Therapy Bioprocessing Market

Figure 19. Cell Therapy Bioprocessing Market Revenue Share, by Technology (2020 and 2028)

Figure 20. Bioreactor: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21. Lyophilization: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 22. Electrodspinning: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 23. Controlflow Centrifugation: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 24. Ultrasonic Lysis: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 25. Genome Editing Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 26. Cell Immortalization Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 27. Viral Vector Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 28. Cell Therapy Bioprocessing Market Revenue Share, by Cell Type (2020 and 2028)

Figure 29. Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 30. Immune Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31. Human Embryonic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32. Pluripotent Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33. Hematopoietic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 34. Cell Therapy Bioprocessing Market Revenue Share, by Indication (2020 and 2028)

Figure 35. Cardiovascular Disease (CVD): Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 36. Oncology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 37. Wound Healing: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 38. Orthopedic: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 39. Others: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 40. 8.2 Cell Therapy Bioprocessing Market Revenue Share, by End User (2020 and 2028)

Figure 41. Hospitals and Clinics: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 42. Diagnostic Centres: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 43. Regenerative Medicine Centers: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 44. Academic and Research Institute: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 45. North America: Cell Therapy Bioprocessing Market, by Key Country – Revenue (2020) (USD Million)

Figure 46. North America: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028 (USD Million)

Figure 47. North America: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

Figure 48. US: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 49. Canada: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 50. Mexico: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 51. Europe: Cell Therapy Bioprocessing Market, by Key Country – Revenue (2020) (USD Million)

Figure 52. Europe: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028 (USD Million)

Figure 53. Europe: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

Figure 54. Germany: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 55. UK: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 56. France: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 57. Spain: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 58. Italy: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 59. Rest of Europe: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 60. Asia Pacific: Cell Therapy Bioprocessing Market, by Key Country – Revenue (2020) (USD Million)

Figure 61. Asia Pacific: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028 (USD Million)

Figure 62. Asia Pacific: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

Figure 63. China: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 64. Japan: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 65. India: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 66. South Korea: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 67. Australia: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 68. Rest of Asia Pacific: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 69. Middle East & Africa: Cell Therapy Bioprocessing Market, by Key Country – Revenue (2020) (USD Million)

Figure 70. Middle East & Africa: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028 (USD Million)

Figure 71. Middle East & Africa: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

Figure 72. UAE: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 73. Saudi Arabia: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 74. South Africa: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 75. Rest of MEA: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 76. South and Central America: Cell Therapy Bioprocessing Market, by Key Country – Revenue (2020) (USD Million)

Figure 77. South and Central America: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028 (USD Million)

Figure 78. South and Central America: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

Figure 79. Brazil: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 80. Argentina: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 81. Rest of SCAM: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 82. Impact of COVID-19 Pandemic in North American Country Markets

Figure 83. Impact of COVID-19 Pandemic in European Country Markets

Figure 84. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 85. Impact of COVID-19 Pandemic in Middle East & Africa Market

Figure 86. Impact of COVID-19 Pandemic in South & Central America Market

Figure 87. Growth Strategies Done by the Companies in the Market, (%)


The List of Companies - Cell Therapy Bioprocessing Market

  1. Fresenius Kabi AG     
  2. Asahi Kasei Corporation         
  3. Sartorius AG              
  4. MERCK KGaA           
  5. THERMO FISHER SCIENTIFIC INC.              
  6. Corning Incorporated             
  7. Cytiva           
  8. Lonza            
  9. Repligen        
  10. Catalent Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Biotechnology : READ MORE..